| Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery (NCT01396525) | Abbott Medical Devices | 2009-03-01 |
| Normalization of Fasting Glucose and the Incidence of Restenosis After Peripheral Angioplasty (NCT01150617) | IRCCS San Raffaele | 2008-12-01 |
| Efficacy Study of Iliac Stents to Treat TASC A-B-C-D Iliac Artery Lesions (NCT00764777) | Flanders Medical Research Program | 2008-12-01 |
| The Complete® SE SFA Study for the Treatment of SFA/PPA Lesions (NCT00814970) | Medtronic Endovascular | 2008-11-01 |
| Data Registry Following Patients Using Supera Stent in the Femoral Arteries (NCT01154751) | Abbott Medical Devices | 2008-11-01 |
| Study Comparing Two Methods of Expanding Stents Placed in Legs of Diabetics With Peripheral Vascular Disease (NCT00827853) | North Texas Veterans Healthcare System | 2008-11-01 |
| The ACTIVE (Use of the Assurant® Cobalt Iliac Stent System in the Treatment of Iliac Vessel Disease) Study (NCT00753337) | Medtronic Endovascular | 2008-10-01 |
| Evaluation of Cilostazol in Combination With L-Carnitine (NCT00822172) | Colorado Prevention Center | 2008-09-01 |
| Placement of Peripherally Inserted Central Venous Catheters (PICC) in Children Guided by Ultrasound (NCT01279642) | Federal University of São Paulo | 2008-08-01 |
| Non-Contrast Enhanced Peripheral Magnetic Resonance Angiography (NCT02823444) | University of Utah | 2008-04-01 |
| Femoral Arterial Access With Ultrasound Trial (NCT00667381) | University of California, Irvine | 2008-04-01 |
| DURABILITY-200: EverFlex 200mm Long Nitinol Stents in TASC C&D Femoropopliteal Lesions (NCT00637741) | Flanders Medical Research Program | 2008-03-01 |
| Drug Eluting Stents In The Critically Ischemic Lower Leg (NCT00510393) | Flanders Medical Research Program | 2008-03-01 |
| Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia (NCT00616980) | Losordo, Douglas, M.D. | 2007-12-01 |
| The Complete® Self-Expanding Stent and Stent Delivery System Registry (NCT00730730) | Medtronic Endovascular | 2007-11-01 |
| Evaluation of the Effect of the Flowaid Device in Increasing Local Circulation in the Leg (NCT00538226) | Rosenblum, Jonathan I., DPM | 2007-10-01 |
| Atrium iCAST Iliac Stent Pivotal Study (NCT00593385) | Atrium Medical Corporation | 2007-10-01 |
| Multicenter Assessment of the Safety and Efficacy of the Minnow Medical GRST™ Peripheral Catheter System (NCT00881257) | Vessix Vascular, Inc | 2007-08-01 |
| Radiofrequency for the Treatment of Peripheral Vascular Occlusive Disease of the Lower Extremities (NCT00751283) | Vessix Vascular, Inc | 2007-08-01 |
| PTA and Drug Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (NCT00471289) | Netherlands Society for Interventional Radiology | 2007-08-01 |
| Belgian Prospective Multicentre Registry on the Performance of the Smart Stent in the Superficial Femoral Artery According to the New Tasc II-classification (NCT00496041) | University Hospital, Ghent | 2007-07-01 |
| Evaluation of the Clinical Significance of Fluorescence Videoangiography With Indocyanine-Green (NCT00876668) | Johann Wolfgang Goethe University Hospital | 2007-06-01 |
| Combination Stem Cell Therapy for the Treatment of Severe Leg Ischemia (NCT00518401) | TCA Cellular Therapy | 2007-06-01 |
| A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral Stent System (NCT00475566) | Abbott Medical Devices | 2007-05-01 |
| Study of the SafeSeal(TM) Hemostasis Patch Following Percutaneous Coronary Artery and Peripheral Vascular Interventions (NCT00481741) | University of Rochester | 2007-05-01 |
| Autologous Bone Marrow Stem Cell Transplantation for Critical, Limb-threatening Ischemia (NCT00434616) | Franziskus-Krankenhaus | 2007-04-01 |
| Study to Evaluate Safety & Effectiveness of Vascular Sealant System (NCT00439309) | Integra LifeSciences Corporation | 2007-04-01 |
| Effects of Cilostazol on VEGF and Oxidative Stress Biomarkers in Hemodialysis Patients With Peripheral Vascular Disease (NCT00431249) | Tungs' Taichung Metroharbour Hospital | 2007-02-01 |
| A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular Surgery (NCT00519961) | Hoffmann-La Roche | 2007-02-01 |
| Crossover Study With MultiHance vs a Comparator for Peripheral MRA (NCT00408083) | Bracco Diagnostics, Inc | 2006-12-01 |
| RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease (NCT00385385) | ActivBiotics | 2006-10-01 |
| ALD-301 for Critical Limb Ischemia, Randomized Trial (NCT00392509) | Aldagen | 2006-10-01 |
| The Effect of a Diabetes Action Team in Patients Post Infrainguinal Bypass Surgery With and Without Diabetes (NCT00456105) | University of British Columbia | 2006-07-01 |
| Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb Ischemia (NCT00300040) | Biopure Corporation | 2006-05-01 |
| Glycemic Control to Prevent Cardiac Morbidity in Vascular Surgery (NCT00328094) | Beth Israel Deaconess Medical Center | 2006-03-01 |
| RISE: A Clinical Evaluation of the StarClose™ Vascular Closure System (NCT00736086) | Abbott Medical Devices | 2006-03-01 |
| Testosterone Replacement in Diabetes With Vascular Disease (Version 2) (NCT00355537) | Barnsley Hospital | 2006-02-01 |
| Testosterone for Peripheral Vascular Disease (NCT00504712) | Barnsley Hospital | 2006-02-01 |
| Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers (NCT00189540) | AnGes USA, Inc. | 2005-08-01 |
| Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures (NCT00154141) | Ethicon, Inc. | 2005-06-01 |
| Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease (NCT00113009) | Valentis | 2005-03-01 |
| Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent Claudication (NCT00117650) | Genzyme, a Sanofi Company | 2005-02-01 |
| Prime Time for Superficial Femoral Artery (SFA) - The SFA Study (NCT00902317) | Arizona Heart Institute | 2004-11-01 |
| Stem Cell Injection for Peripheral Vascular Disease (NCT00278603) | Northwestern University | 2004-10-01 |
| Systematic Assessment of Vascular Risk (NCT00378040) | University Health Network, Toronto | 2004-06-01 |
| The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC (NCT00071266) | Kos Pharmaceuticals | 2003-10-01 |
| Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE) (NCT00574782) | AstraZeneca | 2003-09-01 |
| Balloon Angioplasty vs. Cutting Balloon Angioplasty of Femoropopliteal Arteries- a Randomized Controlled Trial (NCT00437905) | Medical University of Vienna | 2003-06-01 |
| Trial of VLTS-589 in Subjects With Intermittent Claudication (NCT00068133) | Valentis | 2003-06-01 |
| Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS) (NCT00660764) | AstraZeneca | 2003-05-01 |
| Study of HGF Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia (NCT00060892) | AnGes USA, Inc. | 2003-04-01 |
| Efficacy and Safety of NM-702 Tablets for the Treatment of Intermittent Claudication (NCT00102050) | Nissan Chemical Industries | 2003-04-01 |
| Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Infrarenal Aorta and Peripheral Arteries (NCT00185276) | Bayer | 2003-03-01 |
| Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft (NCT00067041) | United Therapeutics | 2003-03-01 |
| Prostaglandin E1 (Liprostin) Treatment With Lower Limb Angioplasty for Peripheral Arterial Occlusive Disease (NCT00053716) | Endovasc | 2003-02-01 |
| Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures (NCT00060996) | United Therapeutics | 2003-02-01 |
| Association of Long-term Conditions With Survival Following Heart Attack in England and Wales (NCT03037255) | Marlous Hall | 2003-01-01 |
| Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent Claudication (NCT00062556) | Kos Pharmaceuticals | 2003-01-01 |
| Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (NCT00442325) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2003-01-01 |
| Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST) (NCT00442845) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2003-01-01 |
| Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease (NCT00059657) | Tanabe Pharma Corporation | 2001-08-01 |
| Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease (NCT00059644) | Tanabe Pharma Corporation | 2001-07-01 |
| Oslo Balloon Angioplasty Versus Conservative Treatment (NCT00222196) | Ullevaal University Hospital | 2000-11-01 |
| Extract of Ginkgo Biloba (EGB 761) and Vascular Function (NCT00029991) | National Center for Complementary and Integrative Health (NCCIH) | 2000-09-01 |
| Magnetic Resonance Imaging to Detect Blood Vessel Inflammation in Patients Undergoing Peripheral Balloon Angioplasty (NCT00004549) | National Heart, Lung, and Blood Institute (NHLBI) | 2000-01-01 |
| Registry of Cardiovascular Disease Patients (NCT01759225) | Maccabi Healthcare Services, Israel | 1998-01-01 |
| New Anastomotic Device for End to End Vascular Anastomosis in the Treatment of Peripheral Vascular Disease (NCT01514916) | Ab Medica Spa | |